Bliss GVS Pharma announces CEO change and new Director appointment

Ceo ResignedCeo Appointed ExternalManagement Changes View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.6%1-day move

₹504.00

prior close

₹505.95

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.7+1.4+0.7+0.4+0.6+0.9+4.5+4.2+5.2+2.2-9.4———

Up moveDown movePending

AI summary

Bliss GVS Pharma announced leadership changes. Mr. Narsimha Kamath steps down as CEO effective July 14, 2026, but continues as Managing Director. Mr. Rahul Adakmol (IIM Bangalore, ex-Dr. Reddy's, Bharat Serums) appointed new CEO from July 15, 2026. Mr. Santosh Parab, a Chartered Accountant with 35 years experience, joins as Non-Executive Non-Independent Director from July 3, 2026.

Likely market impact

CEO transition with MD continuity. New CEO brings pharma experience from Dr. Reddy's and Bharat Serums. Board strengthened with CA director.